Observational, Prospective Cohort Study of the Immunogenicity and Safety of SARS-CoV-2 Vaccines Administered During Pregnancy or Postpartum and Evaluation of Antibody Transfer and Durability in Infants
Observational, Prospective Cohort Study of the Immunogenicity and Safety of SARS-CoV-2 Vaccines Administered During Pregnancy or Postpartum and Evaluation of Antibody Transfer and Durability in Infants is a registry-stage clinical asset sponsored by Emory University in COVID-19. SEO and diligence focus: Licensed or EUA SARS-CoV-2 vaccine, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: COVID-19
Modality: protein therapy
Target: Licensed or EUA SARS-CoV-2 vaccine
Sponsor: Emory University
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 28, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Licensed or EUA SARS-CoV-2 vaccine
View original source fields
Condition raw: COVID-19
Condition normalized: COVID-19
Modality raw: protein therapy
Modality normalized: protein therapy
Target raw: Licensed or EUA SARS-CoV-2 vaccine
Target normalized: Licensed or EUA SARS-CoV-2 vaccine